METASTATIC PDAC
Clinical trials for METASTATIC PDAC explained in plain language.
Never miss a new study
Get alerted when new METASTATIC PDAC trials appear
Sign up with your email to follow new studies for METASTATIC PDAC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug duo takes on deadly pancreatic cancer in early trial
Disease control OngoingThis phase 2 study tests whether adding a new antibody (HLX22) to standard treatment (trastuzumab plus chemotherapy) can shrink tumors better in people with HER2-positive pancreatic cancer that has spread. About 45 adults who have not had prior treatment for metastatic disease wi…
Matched conditions: METASTATIC PDAC
Phase: PHASE2 • Sponsor: Shanghai Zhongshan Hospital • Aim: Disease control
Last updated May 14, 2026 12:01 UTC
-
Desperate patients get early access to experimental cachexia drug
Symptom relief NO_LONGER_AVAILABLEThis program gives seriously ill adults with advanced pancreatic cancer and severe weight loss (cachexia) access to an experimental drug called mifomelatide before it is officially approved. It is for patients who have no other good treatment options for their weight loss and can…
Matched conditions: METASTATIC PDAC
Sponsor: Endevica Bio • Aim: Symptom relief
Last updated May 15, 2026 11:53 UTC